Feb. 12, 2025 — Konica Minolta Healthcare Americas, has published a case study by clinicians in the pulmonary and radiology departments at ASST Fatebenefratelli Sacco (Milan, Italy) demonstrating the use of Dynamic Digital Radiography (DDR) to help definitively diagnose diaphragm dysfunction.

Prenuvo has announced FDA clearance for its AI-powered Prenuvo Body Composition report, marking a significant milestone in the company’s growth. Building on this momentum, Prenuvo introduces three major advances: 

Feb. 13, 2025 — Micro-X will develop a full-body mobile CT following the award of an up to $16.4m development contract by the US Advanced Research Projects Agency for Health (ARPA-H).

Feb. 12, 2025 — Cortechs.ai, a supplier of novel imaging solutions for prostate cancer care, and EDAP TMS SA, a provider of robotic energy-based therapies, have announced the successful completion of the world’s first OnQ Prostate-assisted Focal One Robotic HIFU procedure at the University of California, San Francisco (UCSF) Prostate Center. This marks the first clinical application of OnQ Prostate’s patented RSI technology to guide focal therapy, demonstrating how advanced MR-imaging can improve lesion localization and targeting for urologists performing focal therapy.

Feb. 11, 2025 – Harrison.ai, a developer of AI-powered medical diagnostic support and workflow solutions, has announced the accelerated expansion of its operations into the United States — a move supported by US$112 million of Series C funding. The funding will also fuel the company’s product roadmap and continued growth in the UK, EMEA and APAC. 

Feb. 10, 2025 —Ibex Medical Analytics recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Ibex Prostate Detect, an in vitro diagnostic medical device that harnesses AI to generate heatmaps identifying small and rare missed prostatic cancers, acting as a safety net to assist pathologists in ensuring patients receive an accurate diagnosis. 

Feb. 5, 2025 — According to research published in the American Journal of Roentgenology (AJR), photon-counting detector CT (PCD CT) yielded meaningful attenuation increases for gadoxetate disodium at considerably lower doses than previously documented for CT of gadolinium-based contrast agents (GBCAs) —albeit too high for clinical use (approximately 8-times greater than clinical doses).

Feb. 5, 2025 — Results of a new randomized trial involving more than 105,000 women reveals that the use of artificial intelligence (AI) in mammography screening significantly increases cancer detection rates while reducing the workload for radiologists.

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging agent, said it has received positive feedback from its End of Phase II Meeting with the US Food and Drug Administration (FDA) for the development of 99mTc-maraciclatide as a diagnostic agent for use with single-photon emission computed tomography (SPECT-CT) for the visualization and diagnosis of superficial peritoneal endometriosis (SPE) in women aged 16 years of age and older.

Feb. 4, 2025 — Riverain Technologies recently announced it expanded across eight countries in 2024 and added nearly 50 new customers with its ClearRead solutions to clearly, confidently and quickly detect cardiothoracic diseases.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now